Ignite Creation Date:
2025-12-26 @ 11:00 AM
Ignite Modification Date:
2025-12-31 @ 5:46 PM
Study NCT ID:
NCT05472506
Status:
WITHDRAWN
Last Update Posted:
2024-03-15
First Post:
2022-07-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer
Sponsor:
Ikena Oncology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-04
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-20
First Submit QC Date:
None
Study First Post Date:
2022-07-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-14
Last Update Post Date:
2024-03-15
Last Update Post Date Type:
ACTUAL